DOP2002000422A - ANTIBACTERIAL AGENTS. - Google Patents
ANTIBACTERIAL AGENTS.Info
- Publication number
- DOP2002000422A DOP2002000422A DO2002000422A DO2002000422A DOP2002000422A DO P2002000422 A DOP2002000422 A DO P2002000422A DO 2002000422 A DO2002000422 A DO 2002000422A DO 2002000422 A DO2002000422 A DO 2002000422A DO P2002000422 A DOP2002000422 A DO P2002000422A
- Authority
- DO
- Dominican Republic
- Prior art keywords
- formula
- antibacterial agents
- compounds
- useful
- preparing compounds
- Prior art date
Links
- 239000003242 anti bacterial agent Substances 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 4
- 239000000543 intermediate Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/06—Peri-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
La presente invención proporciona compuestos de fórmula (l): en la que Ri-R6 y J y K tienen cualquierade los valores definidos en la memoria descriptiva, y sales farmacéuticamente aceptables de los mismos, que son útiles como agentes antibacterianos. También se describen composiciones farmacéuticas que comprenden uno o más compuestos de fórmula l, pro dimientos para preparar compuestos de fórmuia l e intermedios útiles para preparar compuestos de Fórmula l.The present invention provides compounds of formula (1): wherein Ri-R6 and J and K have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, which are useful as antibacterial agents. Also described are pharmaceutical compositions comprising one or more compounds of formula 1, procedures for preparing compounds of formula 1 and intermediates useful for preparing compounds of Formula 1.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US29924901P | 2001-06-19 | 2001-06-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
DOP2002000422A true DOP2002000422A (en) | 2002-12-30 |
Family
ID=23153973
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DO2002000422A DOP2002000422A (en) | 2001-06-19 | 2002-06-19 | ANTIBACTERIAL AGENTS. |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP1401830A2 (en) |
JP (1) | JP2005501021A (en) |
AU (1) | AU2002302894A1 (en) |
BR (1) | BR0210028A (en) |
CA (1) | CA2446963A1 (en) |
DO (1) | DOP2002000422A (en) |
GT (1) | GT200200104A (en) |
HN (1) | HN2002000150A (en) |
MX (1) | MXPA03009894A (en) |
PA (1) | PA8548401A1 (en) |
PE (1) | PE20030272A1 (en) |
SV (1) | SV2003001089A (en) |
WO (1) | WO2002102793A2 (en) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0414319A (en) * | 2003-09-12 | 2006-11-07 | Warner Lambert Co | quinolone antibacterial agents |
EP1687296A1 (en) * | 2003-11-18 | 2006-08-09 | Warner-Lambert Company LLC | Antibacterial aminoquinazolidinedione derivatives |
WO2012088266A2 (en) | 2010-12-22 | 2012-06-28 | Incyte Corporation | Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3 |
CN103443085B (en) | 2011-03-14 | 2016-03-23 | 南京英派药业有限公司 | Quinazoline diones and application thereof |
TWI527800B (en) | 2011-04-01 | 2016-04-01 | 南京英派藥業有限公司 | 1-(arylmethyl)quinazoline-2,4(1h,3h)-diones as parp inhibitors and the use thereof |
CA2876689C (en) | 2012-06-13 | 2022-04-26 | Incyte Corporation | Substituted tricyclic compounds as fgfr inhibitors |
US9388185B2 (en) | 2012-08-10 | 2016-07-12 | Incyte Holdings Corporation | Substituted pyrrolo[2,3-b]pyrazines as FGFR inhibitors |
US9266892B2 (en) | 2012-12-19 | 2016-02-23 | Incyte Holdings Corporation | Fused pyrazoles as FGFR inhibitors |
HUE036571T2 (en) | 2013-04-19 | 2018-07-30 | Incyte Holdings Corp | Bicyclic heterocycles as fgfr inhibitors |
US10851105B2 (en) | 2014-10-22 | 2020-12-01 | Incyte Corporation | Bicyclic heterocycles as FGFR4 inhibitors |
MA41551A (en) | 2015-02-20 | 2017-12-26 | Incyte Corp | BICYCLIC HETEROCYCLES USED AS FGFR4 INHIBITORS |
EP3259269B9 (en) | 2015-02-20 | 2020-03-04 | Incyte Corporation | Bicyclic heterocycles as fgfr inhibitors |
US9580423B2 (en) | 2015-02-20 | 2017-02-28 | Incyte Corporation | Bicyclic heterocycles as FGFR4 inhibitors |
CL2015003780A1 (en) | 2015-12-30 | 2016-09-16 | Univ Chile | Pyrimido-isoquinolin-quinone derivative compounds, their salts, isomers, acceptable pharmaceutical tautomers; farm compositions; preparation procedure; and its use in the treatment of multiresistant bacterial and bacterial diseases. |
AR111960A1 (en) | 2017-05-26 | 2019-09-04 | Incyte Corp | CRYSTALLINE FORMS OF A FGFR INHIBITOR AND PROCESSES FOR ITS PREPARATION |
US10815249B2 (en) | 2018-02-16 | 2020-10-27 | Sunovion Pharmaceuticals Inc. | Salts, crystal forms, and production methods thereof |
CR20200590A (en) | 2018-05-04 | 2021-04-26 | Incyte Corp | Solid forms of an fgfr inhibitor and processes for preparing the same |
US11174257B2 (en) | 2018-05-04 | 2021-11-16 | Incyte Corporation | Salts of an FGFR inhibitor |
CN111620866A (en) * | 2019-02-27 | 2020-09-04 | 南京药石科技股份有限公司 | Cis-7, 7-difluoro-hexahydro-1H pyrrolo [3,4-c ] pyridine derivative and preparation method thereof |
US11628162B2 (en) | 2019-03-08 | 2023-04-18 | Incyte Corporation | Methods of treating cancer with an FGFR inhibitor |
WO2021007269A1 (en) | 2019-07-09 | 2021-01-14 | Incyte Corporation | Bicyclic heterocycles as fgfr inhibitors |
KR20220100879A (en) | 2019-10-14 | 2022-07-18 | 인사이트 코포레이션 | Bicyclic heterocycles as FGFR inhibitors |
WO2021076728A1 (en) | 2019-10-16 | 2021-04-22 | Incyte Corporation | Bicyclic heterocycles as fgfr inhibitors |
CA3162010A1 (en) | 2019-12-04 | 2021-06-10 | Incyte Corporation | Derivatives of an fgfr inhibitor |
WO2021113479A1 (en) | 2019-12-04 | 2021-06-10 | Incyte Corporation | Tricyclic heterocycles as fgfr inhibitors |
WO2021146424A1 (en) | 2020-01-15 | 2021-07-22 | Incyte Corporation | Bicyclic heterocycles as fgfr inhibitors |
MX2022012833A (en) | 2020-04-14 | 2022-11-07 | Sunovion Pharmaceuticals Inc | (s)-(4,5-dihydro-7h-thieno[2,3-c]pyran-7-yl)-n-methylmethanamine for treating neurological and psychiatric disorders. |
AR126102A1 (en) | 2021-06-09 | 2023-09-13 | Incyte Corp | TRICYCLIC HETEROCYCLES AS FGFR INHIBITORS |
WO2023066283A1 (en) | 2021-10-20 | 2023-04-27 | Insilico Medicine Ip Limited | Methionine adenosyltransferase 2a (mat2a) inhibitors and uses thereof |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1311573A (en) * | 1970-04-27 | 1973-03-28 | Hisamitsu Pharmaceutical Co | Quinazolinedione derivatives |
DE2334266A1 (en) * | 1972-07-07 | 1974-01-31 | Hisamitsu Pharmaceutical Co | PYRIDO SQUARE BRACKET ON 2.3-D SQUARE BRACKET FOR PYRIMIDINE-2,4 (1H, 3H) -DIONE |
JPS5758347B2 (en) * | 1974-04-03 | 1982-12-09 | Hisamitsu Pharmaceutical Co | |
JPS5761743B2 (en) * | 1974-04-25 | 1982-12-25 | Hisamitsu Pharmaceutical Co | |
DE2446543A1 (en) * | 1974-09-28 | 1976-04-15 | Hoechst Ag | Monoazomethine pigments - from 3-hydroxy 4-formylnaphthalic acid or derivs. |
DE2614148A1 (en) * | 1976-04-02 | 1977-10-20 | Henkel & Cie Gmbh | OXIDIZING AGENTS, BLEACHING AGENTS AND DETERGENTS WITH A BLEACH ACTIVATOR CONTENT |
IT1228293B (en) * | 1989-02-06 | 1991-06-07 | Angeli Inst Spa | BENZODERIVATES OF HETEROCYCLIC COMPOUNDS CONTAINING NITROGEN. |
WO1994014809A1 (en) * | 1992-12-23 | 1994-07-07 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Anellated uracil derivates |
JPH09208543A (en) * | 1995-11-29 | 1997-08-12 | Ono Pharmaceut Co Ltd | Production of isocyanate derivative and its related compound |
EP0896961A4 (en) * | 1995-12-28 | 1999-04-07 | Fuji Chem Ind Co Ltd | Process for the preparation of 3-dihalobenzyl-2,4-quinazolinedione derivatives |
DE69701647T2 (en) * | 1996-02-01 | 2000-09-07 | Sumitomo Chemical Co | Process for the preparation of dioxoquinazolines |
JPH09295977A (en) * | 1996-04-30 | 1997-11-18 | Terumo Corp | Pyridopyrimidine derivative and medicinal composition containing the same |
WO1998018781A2 (en) * | 1996-10-28 | 1998-05-07 | Versicor, Inc. | Fused 2,4-pyrimidinedione combinatorial libraries, their preparation and the use of fused 2,4-pyrimidinediones derivatives as antimicrobial agents |
SI1028950T1 (en) * | 1997-10-28 | 2003-08-31 | Warner-Lambert Company Llc | 7-substituted quinazolin-2,4-diones useful as antibacterial agents |
US7094780B1 (en) * | 2000-01-24 | 2006-08-22 | Warner Lambert Company Llc | 3-aminoquinazolin-2,4-dione antibacterial agents |
EP1288216A1 (en) * | 2000-04-18 | 2003-03-05 | Sumitomo Pharmaceuticals Company, Limited | Tricyclic quinazolinediones |
JP2002284699A (en) * | 2001-03-28 | 2002-10-03 | Sumitomo Pharmaceut Co Ltd | Curative for visual cell degenerative disease |
-
2002
- 2002-05-13 EP EP02730582A patent/EP1401830A2/en not_active Withdrawn
- 2002-05-13 BR BR0210028-2A patent/BR0210028A/en not_active IP Right Cessation
- 2002-05-13 MX MXPA03009894A patent/MXPA03009894A/en unknown
- 2002-05-13 WO PCT/IB2002/001768 patent/WO2002102793A2/en not_active Application Discontinuation
- 2002-05-13 AU AU2002302894A patent/AU2002302894A1/en not_active Abandoned
- 2002-05-13 CA CA002446963A patent/CA2446963A1/en not_active Abandoned
- 2002-05-13 JP JP2003506266A patent/JP2005501021A/en not_active Withdrawn
- 2002-05-31 GT GT200200104A patent/GT200200104A/en unknown
- 2002-06-18 HN HN2002000150A patent/HN2002000150A/en unknown
- 2002-06-18 PE PE2002000523A patent/PE20030272A1/en not_active Application Discontinuation
- 2002-06-18 SV SV2002001089A patent/SV2003001089A/en unknown
- 2002-06-19 DO DO2002000422A patent/DOP2002000422A/en unknown
- 2002-06-19 PA PA20028548401A patent/PA8548401A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
CA2446963A1 (en) | 2002-12-27 |
PA8548401A1 (en) | 2003-05-14 |
PE20030272A1 (en) | 2003-03-21 |
AU2002302894A1 (en) | 2003-01-02 |
SV2003001089A (en) | 2003-03-18 |
WO2002102793A2 (en) | 2002-12-27 |
HN2002000150A (en) | 2002-09-13 |
MXPA03009894A (en) | 2004-02-17 |
WO2002102793A3 (en) | 2003-04-10 |
GT200200104A (en) | 2003-02-11 |
EP1401830A2 (en) | 2004-03-31 |
JP2005501021A (en) | 2005-01-13 |
BR0210028A (en) | 2004-06-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DOP2002000422A (en) | ANTIBACTERIAL AGENTS. | |
UY27424A1 (en) | ANTIDIABETIC AGENTS | |
CR7956A (en) | INTERMEDIATE ANTIBACTERIAL INDOLONA OXAZOLIDINONES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | |
ATE433447T1 (en) | PYRIMIIDINE COMPOUNDS | |
CR7332A (en) | INHIBITORS OF THE FACTOR Xa AND OTHER SERINE PROTEASES INVOLVED IN THE CASCADA DE LA COAGULACION | |
UY27226A1 (en) | PIRAZOLOPIRIMIDINAS AS THERAPEUTIC AGENTS | |
ECSP066643A (en) | PIRIDO [2,3-d] PIRIMIDINA-2,4-DIAMINAS AS PDE 2 INHIBITORS | |
ECSP034773A (en) | PIRAZOLOPIRIMMIDINAS AS THERAPEUTIC AGENTS | |
UY27350A1 (en) | AZAINDOLS | |
ATE296826T1 (en) | PYRAZOLO(1,5)PYRIDINE DERIVATIVES | |
SE0302811D0 (en) | Novel compounds | |
DE60314623D1 (en) | SUBSTITUTED PYRAZOLOPYRIMIDINES | |
SE0400043D0 (en) | New compounds | |
ATE300541T1 (en) | PYRAZOLOPYRIDINE DERIVATIVES | |
SE0302139D0 (en) | Novel compounds | |
SE0403171D0 (en) | New compounds | |
PA8568101A1 (en) | INDOLIL-UREA DERIVED FROM USEFUL TIENOPIRIDINS AS ANTIANGIOGEN AGENTS, AND PROCEDURES FOR USE | |
CY1113175T1 (en) | SULFONAMIDIS UNION AND ITS APPLICATION | |
UY29999A1 (en) | "N-PIRAZINIL-PHENYLSULPHONAMIDS, PROCEDURES AND COMPOUNDS AVERAGE USED IN ITS PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND APPLICATIONS" | |
UY27514A1 (en) | BASIC LINEAR COMPOUNDS THAT HAVE NK-2 ANTAGONIST ACTIVITY AND ITS FORMULATIONS. | |
ATE274515T1 (en) | PYRAZOLOPYRIDINE DERIVATIVES | |
DOP2002000386A (en) | ANTIBACTERIAL AGENTS | |
ATE373000T1 (en) | PYRAZOLOPYRIDINE DERIVATIVES AS ANTHERPESICS | |
SE0403118D0 (en) | New compounds 2 | |
UY27340A1 (en) | ANTIBACTERIAL AGENTS |